Efficient estimation of AUC in nested case-control studies |
Anil Chaturvedi |
National Cancer institute |
PLCO |
Mar 31, 2017 |
PLCO-269 |
Germline genetics of metastasis: an across cancer analysis |
Lisa Mirabello |
National Cancer Institute, NIH |
PLCO |
Mar 29, 2017 |
PLCO-267 |
A case-crossover study of air pollution exposure and lung cancer related mortality in PLCO |
Jason Wong |
National Cancer Institute |
PLCO |
Mar 24, 2017 |
PLCO-264 |
The use of marginal structural model to determine the effect of non-steroidal anti-inflammatory drug use on the risk of prostate and ovarian cancer |
Omonefe Omofuma |
University of south Carolina |
PLCO |
Mar 17, 2017 |
PLCO-265 |
Molecular characterization of bladder tumors and studies of etiologic heterogeneity in the PLCO Trial |
Stella Koutros |
National Cancer Institute |
PLCO |
Mar 14, 2017 |
2016-0045 |
Pancreatic Cancer Prediction using Machine Learning |
Akshay Bodkhe |
San Jose State University |
PLCO |
Mar 2, 2017 |
PLCO-259 |
PSA velocity and prostate cancer mortality in the PLCO Cancer Screening Trial |
Kathryn Barry |
University of Maryland School of Medicine |
PLCO |
Mar 1, 2017 |
PLCO-261 |
Genetic ancestry of African Americans who have been already genotyped in PLCO |
Neal Freedman |
NCI |
PLCO |
Mar 1, 2017 |
PLCO-263 |
Building a Common Data Model for Cancer Research |
Guoqian Jiang |
Mayo Clinic |
PLCO |
Feb 25, 2017 |
PLCO-258 |
BMI, weight change and the risk of colorectal cancer in the PLCO Cancer Screening Trial |
Kathryn Barry |
University of Maryland School of Medicine |
PLCO |
Feb 23, 2017 |
PLCO-260 |
Fertility, Ectopic Pregnancy, and Ovarian Cancer Risk |
Suneeta Senapati |
University of Pennsylvania Perelman School of Medicine |
PLCO |
Feb 23, 2017 |
PLCO-262 |
Distributed Automated Tuberculosis and Cancer Diagnosis |
Jochen Nessel |
Rai and Rohl Technologies, Inc. |
PLCO |
Feb 22, 2017 |
PLCO-256 |
Phase 3 validation of early detection biomarker panel for pancreatic cancer |
Ann Oberg |
Mayo Clinic |
PLCO |
Feb 2, 2017 |
2016-0041 |
Compliance and Mortality |
Paul Pinsky |
NCI |
PLCO |
Feb 2, 2017 |
PLCO-255 |
Melanoma Data Analysis2 |
Hovig Devejian |
FSU |
PLCO |
Jan 24, 2017 |
PLCO-253 |
Request for access to the Ovarian Biomarkers data in order to correlate values with those obtained on our multiplex platform |
Amy Skubitz |
University of Minnesota |
PLCO |
Jan 20, 2017 |
PLCO-254 |
Absolute Risk Model Evaluation and Integration of Imaging Biomarkers for Early Detection and Risk Assessment of Cancer |
Jae Lee |
Moffitt Cancer Center |
PLCO |
Jan 12, 2017 |
PLCO-248 |
Examining Trends in Prostate Cancer Diagnosis, Treatment and Mortality |
D. Duane Baldwin |
Loma Linda University Health |
PLCO |
Jan 12, 2017 |
PLCO-247 |
Physical activity and reproductive characteristics in the development of postmenopausal breast cancer |
Chuanbo Xie |
Sun Yat-sen University Cancer Center |
PLCO |
Jan 10, 2017 |
PLCO-249 |
Diet and risk of glioma in the PLCO Study |
Ai-Seon Kuan |
Cancer Epidemiology Unit, University of Oxford |
PLCO |
Jan 5, 2017 |
PLCO-252 |